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The central nervous system (CNS) monitors modifications in metabolic parameters or
hormone levels and elicits adaptive responses such as food intake regulation. Particularly,
within the hypothalamus, leptin modulates the activity of pro-opiomelanocortin (POMC)
neurons which are critical regulators of energy balance. Consistent with a pivotal role
of the melanocortin system in the control of energy homeostasis, disruption of the
POMC gene causes hyperphagia and obesity. MicroRNAs (miRNAs) are short noncoding
RNA molecules that post-transcriptionally repress the expression of genes by binding to
3′-untranslated regions (3′UTR) of the target mRNAs. However, little is known regarding
the role of miRNAs that target POMC 3′UTR in the central control energy homeostasis.
Particularly, their interaction with the leptin signaling pathway remain unclear. First, we
used common prediction programs to search for potential miRNAs target sites on
3′UTR of POMC mRNA. This screening identified a set of conserved miRNAs seed
sequences formir-383,mir-384-3p, andmir-488. We observed thatmir-383,mir-384-3p,
and mir-488 are up-regulated in the hypothalamus of leptin deficient ob/ob mice. In
accordance with these observations, we also showed that mir-383, mir-384-3p, and
mir-488 were increased in db/db mice that exhibit a non-functional leptin receptor. The
intraperitoneal injection of leptin down-regulated the expression of these miRNAs of
interest in the hypothalamus of ob/ob mice showing the involvement of leptin in the
expression of mir-383, mir-384-3p, and mir-488. Finally, the evaluation of responsivity
to intracerebroventricular administration of leptin exhibited that a chronic treatment with
leptin decreased mir-488 expression in hypothalamus of C57BL/6 mice. In summary,
these results suggest that leptin modulates the expression of miRNAs that target POMC
mRNA in hypothalamus.
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Introduction
The control of energy homeostasis is finely tuned by endocrine and neural mechanisms that
cooperate to maintain the balance between caloric intake and energy expenditure. In this
respect, the central nervous system (CNS) continuously monitors modifications in metabolic
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parameters (blood glucose) and/or hormones (insulin or leptin)
and elicits adaptive responses such as food intake regulation
and autonomic nervous system modulation (Cowley et al., 2001;
Ibrahim et al., 2003; Plum et al., 2006; Mounien et al., 2010).
It is now clearly established that specific neuronal networks
of the hypothalamus play a pivotal role in energy homeostasis
regulation (Morton et al., 2006). For instance, within the arcuate
nucleus of the hypothalamus, pro-opiomelanocortin (POMC)
neurons are critical regulators of energy balance and glucose
homeostasis (Porte et al., 2002; Mounien et al., 2005, 2009, 2010;
Parton et al., 2007; Hill et al., 2010). In accordance with this
aspect, it has been shown that the disruption of the POMC
and melanocortin receptor 4 (MC4R) genes in mice models
causes obesity (Huszar et al., 1997; Yaswen et al., 1999), while
MC3R gene-deficient mice have normal food consumption but
accumulate fat (Chen et al., 2000). In humans, obesity can result
from genetic deficiencies which produce a lack in the leptin
receptor, POMC, or MC3/4R (Lee, 2009).
One important goal of current research is to identify the
molecular mechanisms involved in the control of the expression
of genes that are important to maintain energy homeostasis.
It has long been acknowledged that the leptin acts as a key
regulator of hypothalamic genes expression via different signaling
cascades (Morton et al., 2006). For instance, when the leptin
binds to the extracellular domain of its receptor (LepR), it
recruits and activates the Janus kinase (JAK). JAK binds to and
phosphorylates LepR at the same time. This mechanism activates
signal transducer and activator of transcription 3 (STAT3). Once
phosphorylated, STAT3 binds to POMC promoters, stimulating
POMC expression (Morton et al., 2006). Interestingly, mice with
genetic inactivation of STAT3 gain body weight (Gao et al., 2004).
Altogether, the above collected data strongly suggest that the
stability of energy homeostasis during environmental variation
requires metabolic adjustements that are achieved through a fine
regulation of genes’s expression.
Because microRNAs (miRNAs) have been depicted to be
another layer of gene regulation, it is not surprising that
they are also involved in leptin-regulated gene expression.
The miRNAs are endogenous, single-stranded, small, ∼22-
nucleotides noncoding RNAs, and are generally regarded as
negative regulators of gene expression because they inhibe
translation and/or promot mRNA degradation by base pairing
to complementary sequences within the 3′untranslated region
(3′UTR) of protein-coding mRNA transcripts (Bagga et al.,
2005). Several studies identified miRNAs that are differentially
expressed in the liver, pancreas, and adipose tissue of leptin-
deficient (ob/ob) or leptin receptor-deficient (db/db) mice
compared to the control animals (Lovis et al., 2008; Li et al., 2009;
Nakanishi et al., 2009; Xie et al., 2009). Among these miRNAs,
it has been shown that the pancreatic expression levels of mir-
375 are aberrant in ob/ob mice, indicating that they contribute
to insulin resistance in this model (Poy et al., 2009). Additional
studies provide evidence for the involvement of mir-335 in lipid
metabolism of the liver and the adipose tissue of ob/ob and db/db
mice (Nakanishi et al., 2009). In the context of CNS, it has been
shown that mir-200a, mir-200b, and mir-429 are up-regulated in
the hypothalamus of ob/ob and db/db mice (Crépin et al., 2014).
Recently, it has been shown that conditional deletion of the
RNAse III ribonuclease Dicer (involved in miRNAs maturation)
from POMC-expressing cells results in obesity and diabetes
which is associated with a neurodegenerescence of POMC
neurons in the hypothalamus (Schneeberger et al., 2012;
Greenman et al., 2013). These observations strongly suggest that
miRNAs are important regulators of POMC neuron activity.
In this context, the characterization of the miRNAs that target
directly POMC mRNA and their interaction with the leptin
signaling pathway remain unclear.
In the present study, we focused our attention on the specific
miRNAs targeting POMC 3′UTR. Based on bioinformatic
predictions of their involvement in POMC-signaling pathway
and their conservation among vertebrates, the expression ofmir-
383, mir-384-3p, and mir-488 were investigated in models of
obesity characterized by a decrease of POMC mRNA expression
and leptin insufficiency (ob/ob) or leptin insensitivity (db/db)
(Mizuno et al., 1998). Then, we further analyzed the role of leptin
on the expression level of these miRNAs using different models
of leptin-treated mice.
Methods
Animals
Experiments were carried out on different types of mice:
C57BL/6, ob/ob, and db/db mice were purchased from Charles
River (France). Fluorescence in situ hybridization (FISH)
experiments were performed using male POMC-Tau-Topaz GFP
transgenic mice developed by Pinto et al. (2004). To assess GFP
expression in POMC-Tau-Topaz GFP mice, we carried out PCR
on tail genomic DNA. GFP transgene was detected using the
forward primer 5′-GCCACAAGTTCAGCGTGTCC-3′ and the
reverse primer 5′-GCTTCTCGTTGGGGTCTTTGC-3′, with the
following PCR conditions: 5min at 95◦C, 36 cycles at 95◦C for
30 s, 64◦C for 30 s, and 72◦C for 40 s, followed by a final step at
72◦C for 7min. The amplicon size was 573 bp.
All animals were individually housed in a pathogen-free
facility at controlled temperature on a 12/12 h light/dark cycle
(lights from 0700 to 1900 h) with standard pellet diet (AO4)
and water available ad libitum. All experiments were conducted
in conformity with the rules set by the EC Council Directive
(2010/63/UE) and the French “Direction Départementale de la
Protection des Populations des Bouches-du-Rhône” (License no.
13.435 and no. 13.430). Protocols used are in agreement with
the rules set by the Comité d’Ethique de Marseille, our local
Committee for Animal Care and Research. Every precaution
was taken to minimize animal stress and the number of
animals used.
miRNA Prediction
To search for miRNAs that might regulate mouse POMC
expression, we used the following public prediction algorithms
and database: Targetscan (http://www.targetscan.org/) and
miRanda (http://www.microrna.org/microrna/home.do). Using
these different algorithms, we selected the miRNAs that are
conserved among the vertebrates (Targetscan) and that have a
good mirSVR scores (miRanda).
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Surgery and Injections
For the intraperitoneal injection (i.p.), ob/ob, and C57BL/6 mice
were injected between 1100 and 1200 h with recombinant murine
leptin (Peprotech, France) (n = 5, 5mg/kg) or saline. Mice were
sacrified 4 h after i.p. injection.
Intracerebroventricular (i.c.v) cannula placement and
injections were performed as described previously (Girardet
et al., 2011). Animals were anesthetized by an i.p. injection
of ketamine (100mg/kg; Imalgen 1000, Merial, France) and
xylazine (6mg/kg; Rompun, Bayer, France), and placed in a
digital stereotaxic apparatus (Model 502600,WPI) coupled to the
neurostar software (Neurostar GmbH, Germany). A 26-gauge
stainless steel cannula was implanted into the lateral ventricle at
the following coordinates: 0.3mm posterior to bregma, 1.1mm
lateral to themidline, and 2.6mm ventral to the skull surface. The
cannula was secured to the skull with dental cement and sealed
with removable obturators. The animals were sutured, placed in
individual cages and allowed to recover for 7 days. During this
recovery period, animals were injected with physiological saline
every day for habituation. One week post-surgery, mice were
administered either 10µl (2µl/min) of physiological saline or
leptin (0.5µg/µl) solution at the beginning of the dark phase.
The correct cannula positioning was checked for each animal
at the end of the experiment by cresyl violet staining of brain
sections (Supplementary Figure 1).
The exogenous leptin was detected in the hypothalamus of
ob/ob and C57BL/6 mice after i.p. and i.c.v injection by western
blotting (Supplementary Figure 2 and Supplementary Material).
Quantitative RT-PCR (qRT-PCR) Analysis
Mice were killed by decapitation and the different brain
regions were collected and frozen in liquid nitrogen and
stored at −80◦C until protein or RNA extraction. Total
RNA was extracted with TRI Reagent (Sigma-Aldrich, France).
For RNA quantification, cDNA was synthetized by 2µg
total RNA with M-MLV Reverse Transcriptase (Promega
Corporation, WI, USA). For miRNAs quantification, cDNA
was synthetized by 1µg total RNA by the qScript microRNA
Quantification System (Quanta Biosciences, MD, USA). For
real-time PCR, we used LightCycler 480 (Roche, Germany).
We used Pomc forward primer 5′-TGAACATCTTTGTCCCC
AGAGA-3′ and reverse 5′-TGCAGAGGCAAACAAGATTGG-
3′; β Actin forward primer 5′-GATCTGGCACCACACCTT
CTACA-3′ and reverse 5′- TGGCGTGAGGGAGAGCATAG-
3′; Gapdh forward primer 5′- TTCTCAAGCTCATTTCCT
GGTATG-3′ and reverse primer 5′- GGATAGGGCCTCTCTTG
CTCA-3′. PCR was initiated by one cycle of 95◦C for 10min,
followed by 40 cycles of 10 s at 95◦C, 30 s at 60◦C, and 2 s at
72◦C, followed by a holding at 40◦C. FormiRNAs,U6 and Sno202
were used as normalizers for miRNA quantification. For U6 we
used forward primer 5′-ATTGGAACGATACAGAGAAGATT-
3′ and reverse primer 5′-GGAACGCTTCACGAATTTG-3′;
Sno202 forward primer 5′-CTTTTGAACCCTTTTCCATCTG-
3′ mir-383 forward primer 5′-CAGATCAGAAGGTGACTGTG-
3′; mir-384-3p forward primer 5′- TGTAAACAATTCCTAGG
CAATGA-3′;mir-471-3p forward primer 5′- TGAAAGGTGCCA
TACTATGTAT-3′,mir-488 forward primer 5′- CCCAGATAATA
GCACTCTCAA-3′; for the reverse primers we used the Universal
Primer (Quanta Biosciences). We performed quantitative
PCR according to the manufacturer’s instructions (Quanta
Biosciences).
miRNA Fluorescent In Situ Hybridization (FISH)
and GFP Immunohistochemistry
For the detection of miRNAs in POMC neurons, POMC-Tau-
Topaz GFP transgenic mice were perfused intracardially with
heparin 10% in PBS-Diethylpyrocarbonate (DEPC)-treated
(0.1% PBS, 0.1 M, pH 7.4) followed by 4% PFA in PBS-DEPC
maintained at 4◦C under ketamine/xylazine anesthesia (100 and
15mg/kg, respectively). The brains were removed and postfixed
for 2 h in 4% PFA/DEPC, cryoprotected for 48 h in 30% sucrose
in PBS/DEPC at 4◦C and frozen in O.C.T. (Tissue-Tek; Sakura
Finetek, USA). Subsequently the brains were sliced at 12µm
thickness from −1.34 to −2.70mm relative to bregma and
transferred serially on poly-L-lysine and gelatin-coated Super
Frost slides (Fisher, PA, USA). Slides were stored at −20◦C
until FISH. The miRNA FISH was based on Thompson et al.
(2007) protocol. Slides were removed from storage at −20◦C
and air dried at 37◦C for 30min then placed in 4 % PFA in
PBS-DEPC for 20min and washed in PBS-DEPC 2 times for
10min. Sections were treated with 10mg/ml proteinase K
for 6min at room temperature and washed in PBS-DEPC for
10min. Fixation with 4% PFA in PBS-DEPC was performed for
15min and rinse in DEPC-treated water. Slides were treated
with acetic anhydride (Triethanolamine, 0.1M, pH 8.0; Acetic
anhydride 1:400) 2 times for 5min and washed with PBS-DEPC
for 10min. Sections were incubated in pre-hybridization buffer
(50 % Formamide; 5× SSC; 0.3mg/ml RNA Yeast; 100µg/ml
heparin; 1× Denhardt’s solution (2% bovine serum albumin,
2% polyvinylpyrrolidone; 2% Ficoll 400); 0.1% Tween 20; 0.1%
CHAPS; 5mM EDTA; 0.3 nmole/ml DNA Random Primer 12-
mer) for 2.5 h. Hybridization was performed overnight at 37◦C in
the same buffer with 3′end 6 Fluorescein amidite (6FAM)-labeled
DNA oligonucleotide probes at 5µg/ml. We used the antisense
probes 5′-AGCCACAGTCACCTTCTGATCTTT-3′-6FAM
for mir-383; 5′-TTACATTGCCTAGGAATTGTTTACATA-3′-
6FAM for mir-384-3p; 5′-AAAACTCTCACGATAATAGAC
CCTT-3′-6FAM for mir-488. Scrambled probes were used for
negative control for each experiment. The scramble sequences
were 5′-TTCCGACAACTGCACTCTATGTTC-3′6FAM for
scramble (sc) mir-383, 5′-CATGAATATTCCGTGGTTAAT
CATTTA-3′6FAM for scmir-384-3p and 5′-AGATTCTCAACCT
GCTTTACAAAGC-3′6FAM for scmir-488. Slides were washed
with 2× SSC for 15min at 37◦C. High-stringency tetramethyl
ammonium chloride (TMAC, Acros Organics, NJ, USA) washes
were performed 2 times for 5min at 54◦C and 1 time for 10min
at 54◦C then rinsed in PBS-DEPC with 0.1% Triton X-100 (PBT)
for 10min. Slides were incubated in PBT with 20% horse serum
for 1 h for blocking. Rabbit polyclonal antibody anti-fluorescein
(1:500, Gen Tex, TX, USA) and mouse monoclonal anti-GFP
(1:500, Abcam, MA, USA) antibodies in PBT with 20% horse
serum were added to sections and incubated for overnight
at 4◦C. Slides were washed three times in PBT for 10min.
Alexa 488 fluor-conjugated goat anti-mouse and Alexa 594
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fluor-conjugated donkey anti-rabbit (1:500, Life Technologies,
France) with PBS 3% horse serum and 0.3% Triton X-100 were
added sequentially to slides for 1.5 h at room temperature and
sections were washed three times with PBS.
Sections were finally coverslipped with mounting medium
for fluorescence microscope preparation. Sections were observed
using a Zeiss LSM 700 confocal microscope (Zeiss, France)
associated to ZEN 2012 software and a DXM 1200 Camera
(Nikon, France) coupled to ACT-1 software. For quantitative
analysis, cells were counted manually using the Image J
analysis system (National Institutes of Health, USA). For
sections stained for both eGFP and miRNA probes, the double
labeled cells were examined at multiple focal levels and at
appropriate magnifications to ensure that single cells were
indeed immunoreactive for both eGFP and miRNA probes.
Because POMC neurons constitute a heterogeneous population
in relation to their sensitivity to regulatory factors (Mounien
et al., 2006a,b; Williams et al., 2010), the average number of cells
counted bilaterally in 8 sections at the anterior and posterior
levels of the arcuate nucleus in each animal (n = 4) was used
for statistical comparisons.
Statistical Analysis
All data are expressed as mean ± SEM. Statistical analysis was
performed by an unpaired 2-tailed Mann-Whitney test. P < 0.05
was considered significant.
Results
Identification and Localization of miRNAs of
Interest in the Hypothalamus
We used common prediction programs (http://www.targetscan.
org and http://www.microrna.org) to search for potential
miRNAs target sites on the 3′UTR of Pomc mRNA. In one
hand, we identified three conserved miRNAS (mir-383, mir-
384-3p, and mir-488) with targetscan.org. In the other hand,
the conserved miRNAS with a good mirSVR scores identified
with microrna.org are mir-384-3p, mir-371-3p, and mir-488
(Figure 1A). The distributions of these miRNAs of interest in the
mouse CNS were investigated by means of quantitative PCR.
The expression profiles of mir-383, mir-384-3p, and mir-488
miRNAs presented many similarities, but also major differences.
Thus, in the CNS, the hypothalamus, brainstem, and cortex
were the three regions that contained the highest densities of
mir-383 miRNAs (Figure 1B). In other CNS structures such as
the cerebellum, hippocampus, and olfactory bulb, much lower
concentrations of mir-383 miRNA were recorded (Figure 1B).
The highest amounts of mir-384-3p miRNAs were found in the
brainstem, cerebellum, and olfactory bulb (Figure 1B). Lower
levels ofmir-384-3pmiRNAs were detected in the hypothalamus,
hippocampus, and cortex (Figure 1B). The mir-488 miRNAs
were widely expressed throughout the CNS with the same
intensity (Figure 1B). It should be noted thatmir-471-3pmiRNA
expression was undetectable whatever the brain region studied
(Figure 1B). Considering these expression patterns, we focused
our work onmir-383,mir-384-3p asmir-488 which are expressed
in the hypothalamus.
FIGURE 1 | Characterization of microRNAs identified as potential
regulators of POMC mRNA expression. (A) Predicted conserved binding
sites for miRNAs were bioinformatically identified in the sequence of the POMC
mRNA 3’ UTR. (B) The four miRNAs with the highest conservation degree
were quantified by qRT-PCR for their presence in the hypothalamus (Hpt),
brainstem (BS), cerebellum (Cb), hippocampus (Hpc), cortex (Cx), and
olfactory bulb (OB) of wild-type mice. Relative expression levels of mir-383,
mir-384-3p, mir-471-3p, and mir-488 are expressed in fold change of the
normalized level obtained in the hypothalamus. Values represent the mean ±
SEM (n = 7). *P < 0.05, **P < 0.01 vs. hypothalamus.
The miRNAs of Interest are Expressed in the
POMC Neurons of the Arcuate Nucleus
In POMC-Tau-Topaz GFP mice model, double-staining of brain
sections with the fluorescein-labeled mir-383 probe and the
antibody against GFP showed that a large proportion of neurons
in the arcuate nucleus contained simultaneously GFP and mir-
383 miRNAs (Figure 2A). Several GFP neurons did not contain
mir-383 miRNAs and, reciprocally, several mir-383 miRNAs-
expressing neurons did not contain GFP protein (Figure 2A).
Similarly, double staining of brain sections with the GFP
antibody and mir-384-3p or mir-488 probes showed that a large
proportion of GFP neurons expressed mir-384-3p or mir-488
miRNAs (Figures 2B,C). Quantitative analysis of double-labeled
neurons showed that, in the whole arcuate nucleus, 80.7 ± 3.4%
of the GFP-positive neurons expressed mir-383 miRNAs, 39.8 ±
2.5% of the GFP-positive cells expressedmir-384-3pmiRNAs and
64.9 ± 3.2% of the GFP- immunoreactive cells contained mir-
488 miRNAs (Figures 2D–F). The proportion of GFP neurons
that exhibitedmir-383,mir-384-3p, ormir-488miRNAs were not
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FIGURE 2 | Expression of mir-383, mir-384-3p, andmir-488 in POMC
neurons of the arcuate nucleus. (A–C) In situ hybridization and
immunofluorescence microscopy detection of miRNAs expression in GFP
positive neurons at the arcuate nucleus level of POMC-Tau-Topaz GFPmice
model. (D–F)Quantitative analysis of GFP-positive neurons that were labeled
with miRNA oligonucleotide probes at anterior (arc. ant.) and posterior (arc.
post.) level of the arcuate nucleus. Scale bar= 50µm.White arrowheads point
to POMC neurons expressing miR-383, miR-384-3p or miR-488 miRNA.
different in the anterior and posterior subdivisions of the arcuate
nucleus (Figures 2D,F). The control scrambled probes did not
produce any labeling (Supplementary Figure 3).
The miRNA of Interest are Up-regulated in the
Hypothalamus of ob/ob and db/db Mice Models
To evaluate whether leptin signaling in hypothalamus is essential
for the expression of mir-383, mir-384-3p, or mir-488 miRNAs,
we analyzed the expression of these miRNAs among groups
of leptin-deficient (ob/ob) mice and C57BL/6 controls. The
levels of mir-383, mir-384-3p, and mir-488 miRNAs in the
hypothalamus of 16-week-old ob/ob and C57BL/6 mice were
determined by qRT-PCR. Absence of leptin resulted in a
significant increase inmir-383,mir-384-3p, and mir-488miRNAs
(+400%,+101%; P < 0.05 and+605%; P < 0.001, respectively)
(Figure 3A).
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FIGURE 3 | Expression of miRNAs in the hypothalamus of ob/ob and
db/db mice. (A) Hypothalamic mir-383, mir-384-3p, and mir-488 expression
in ob/ob and control mice at 16 weeks of age. (B) Hypothalamic miRNAs
expression in db/db and control mice at 16 weeks of age. Values represent the
mean ± SEM (n = 5− 10). *P < 0.05, ***P < 0.001.
Because the lack of circulating leptin was associated with
a significant increase in the miRNAs of interest, we measured
the expression of mir-383, mir-384-3p, and mir-488 miRNAs in
the hypothalamus of db/db mice, a model that exhibits a non-
functional leptin receptor leading to impaired leptin signaling.
As shown in Figure 3B, the mir-383, mir-384-3p, and mir-
488 miRNAs levels were over-expressed in 16-week-old db/db
mice compared to C57BL/6 animals (+25, +32 and +110%,
respectively; P < 0.001).
The Expression of Selected miRNAs are
Restored in the Hypothalamus of ob/ob Mice
after Peripheral Leptin Administration
The above data suggest that leptin may be involved in the
regulation of the expression ofmir-383,mir-384-3p, andmir-488
miRNAs in the hypothalamus. To directly test this hypothesis,
ob/ob mice were i.p. injected with leptin at dose of 5mg/kg and
the hypothalamic expression of mir-383, mir-384-3p, and mir-
488 miRNAs was evaluated by qRT-PCR 4 h later. We observed
an up-regulation of mir-383, mir-384-3p, and mir-488 miRNAs
in 12-week-old ob/ob animals treated with vehicle compared
to C57BL/6 control mice (+42, +32%; P < 0.05 and +137%;
P < 0.01, respectively) (Figure 4). As expected, leptin treatment
FIGURE 4 | Expression of miRNAs in the hypothalamus of peripheral
leptin-treated ob/ob mice and saline-treated ob/ob and wild-type
animals. Hypothalamic miRNA expression in peripheral saline-treated animals
and leptin-treated ob/ob mice at 12 weeks of age. Values represent the mean
± SEM (n = 5). *P < 0.05, **P < 0.01.
significantly reduced hypothalamic expression of mir-383, mir-
384-3p, and mir-488 miRNAs in 12-week-old ob/ob animals
treated with leptin compared to vehicle-treated ob/ob mice
(−25, −21%; P < 0.05 and −58%; P < 0.01, respectively)
(Figure 4).
The Expression of mir-488 is Decreased in the
Hypothalamus of C57BL/6 Mice after Central
Leptin Administration
Because leptin exhibits a large range of effect at peripheral
level (Margetic et al., 2002), we next investigated the effect
of a daily i.c.v leptin administration (5µg/mice) during 4
days on hypothalamic expression of mir-383, mir-384-3p, and
mir-488 miRNAs. The sub-chronic i.c.v leptin administration
significantly reduced food consumption and body weight gain
in C57BL/6 mice when compared with the control animals
(Figures 5A,B). The i.c.v administration of leptin significantly
increased POMC mRNA level in the hypothalamus of leptin-
treated group compared with the vehicle-treated animals (+62%;
P < 0.05) (Figure 5C). Concurrently, the effects of leptin on
miRNAs levels were evaluated. Chronic i.c.v administration of
leptin had no effect on mir-383 and mir-384-3p miRNAs levels
(Figure 5D). In contrast, leptin significantly decreased mir-488
miRNA contents in the hypothalamus after treatment (−60%;
P < 0.01) (Figure 5D).
Discussion
The relevance of miRNAs in the function of melanocortin
pathways has been recently highlighted by the deletion of Dicer
in POMC-expressing cells which led to a postnatal ablation of
POMC neurons resulting in obesity (Schneeberger et al., 2012;
Greenman et al., 2013). In this models, the absence of Dicer in
POMC-positive neurons led to hyperphagia (Schneeberger et al.,
2012) and a decrease of energy expenditure without any increase
in food intake (Greenman et al., 2013). Taken together, the data
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FIGURE 5 | Effect of leptin central administration on miRNA levels
in the hypothalamus. (A) Daily food intake in saline-injected and
leptin-treated mice at baseline (day 1 before injection) and with daily
i.c.v injections of leptin (2.5µg; days 2–5). (B) Effect of leptin treatment
on body weight. (C) Hypothalamic POMC mRNA expression in i.c.v
leptin-treated mice and saline-treated animals. (D) Hypothalamic mir-383,
mir-384-3p, and mir-488 expression in i.c.v leptin-treated mice and
saline-treated animals. Arrows indicate the injections. Values represent
the mean ± SEM (n = 7). *P < 0.05, **P < 0.01, ***P < 0.001 vs.
saline-treated animals.
suggests that miRNAs are essential for the integrity of POMC
neuron activity.
Firstly, we studied the pattern of expression of miRNAs, i.e.,
mir-383, mir-384-3p, and mir-488, in the CNS. It is already
established that these miRNAs are highly expressed in the brain
(Chiang et al., 2010). In agreement with this data, we have
found by using qRT-PCR that the highest concentrations of
mir-383 occurred in the hypothalamus, brainstem, and cortex.
The highest amounts of mir-384-3p miRNAs were found in the
brainstem, cerebellum, and olfactory bulb whilemir-488miRNAs
were widely expressed throughout the structures studied. In
many brain regions, mir-383, mir-384-3p, and mir-488 miRNAs
distribution patterns did notmatch each other suggesting that the
threemiRNAs also exert specific roles. For the first time, we found
that the miRNAs encoding the mir-383, mir-384-3p, and mir-
488 miRNAs are abundant in the arcuate nucleus. This indicates
that a large proportion of the different cell types present in the
nucleus are equipped with these miRNAs of interest. The double-
staining of POMC-Tau-Topaz GFP mice brain sections with the
fluorescein-labeled probes and an antibody against GFP revealed
that a high proportion of POMC neurons express mir-383, mir-
384-3p, and mir-488, suggesting that these miRNAs target the
expression of protein-coding genes that are distributed in this
neuronal population. Although mir-383, mir-384-3p, and mir-
488miRNAs were evenly distributed along the rostro-caudal axis
of the arcuate nucleus, the proportion of double labeled GFP/mir-
383, GFP/mir-384-3p, and GFP/mir-488 neurons did not reflect
each other in terms of the proportion of their distribution. These
observations are consistent with previous reports demonstrating
that POMC neurons constitute an heterogeneous population in
relation to their sensitivity to regulatory factors (Mounien et al.,
2006a,b; Williams et al., 2010).
In the present context, of special interest is the fact that the
POMC neurons are essential for the integration of peripheral
signals such as hormones (leptin and insulin) and/or nutrients
(glucose) (Morton et al., 2006). For instance, it has been
shown recently that leptin directly acts through POMC neurons
to stimulate energy expenditure (Berglund et al., 2012). One
important goal of current research is to clarify the molecular
mechanism involved in the integration of these multiple
peripheral metabolic signals such as leptin. One path to reach
this goal is to identify the intracellular mediators that allow
these POMC neurons to respond to energy status modifications.
Interestingly, we observed that the miRNAs targeting POMC
mRNAs are up-regulated in ob/ob and db/db mice models. This
data provides the first evidence that the expressions of mir-383,
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mir-384-3p, and mir-488 are associated with an impaired leptin
signaling pathway. However, the miRNAs that target POMC
3′UTR may modulate the melanocortin system at other levels
notably by regulating the expression and/or activity of the
prohormone convertases PC1 and PC2 which are required for
the processing of POMC and the formation of α-melanocyte-
stimulating hormone (Smith and Funder, 1988). In accordance
with this hypothesis, we observed in the databases that mir-488
can also target PC1 3′UTR. In accordance with this hypothesis,
PC1 gene expression is different in the arcuate nucleus of leptin-
treated obese ob/ob mice (Nilaweera et al., 2003). It is also
conceivable that miRNAs may control the biosynthesis of agouti-
related protein; the endogenous antagonist of melanocortin
receptors MC3R and MC4R (Ollmann et al., 1997).
Several miRNAs have been reported to be differentially
expressed in the hypothalamus of ob/ob and db/db mice,
but their precise role in the regulation of the hypothalamus
function remains to be determined. Recently, it has been shown
that mir-200a, mir-200b, and mir-429 are up-regulated in the
hypothalamus of ob/ob and db/db mice (Crépin et al., 2014).
The same group showed that daily injection of a pegylated
leptin antagonist predisposed rats to obesity, promoted leptin
resistance and modified the hypothalamic miRNA expression
profile (Benoit et al., 2013). In our study, we identified the
presence of new miRNAs that are expressed differently in the
hypothalamus of ob/ob and db/db animals compared to control
mice. Additional studies will be necessary to understand the
regulation of these different miRNAs in the hypothalamus during
the progressive onset of the obese phenotype and to determine
their complex role in the regulation of feeding behavior.
We observed that the fold change modification of the selected
miRNAs in the ob/ob mice increased in an age dependent
way. These results suggest that age positively regulates miRNAs
expression in ob/ob mice. In accordance with this hypothesis, it
has been also shown thatmir-184 is differentially expressed in the
pancreatic islets of ob/ob mice from age 4–16 weeks (Tattikota
et al., 2014). The present study shows that leptin peripheral
treatment rescues the expression of mir-383, mir-384-3p, and
mir-488 in ob/obmice. Thus, together with the altered expression
of these miRNAs in ob/ob and db/db mice, these results support
the idea that leptin plays an important role in the expression
of the miRNAs that target POMC mRNA in the hypothalamus.
However, leptin exhibits a wide range of effects at peripheral level
(Margetic et al., 2002) and its effect on miRNAs expression in the
hypothalamus could thus be indirect. In order to test the effect at
central level, we then performed chronic i.c.v infusion of leptin.
Surprisingly, i.c.v administration of leptin in mice only decreased
the expression of mir-488 in the hypothalamus suggesting that
the expression of mir-488 is under the control of leptin. The
absence of effect by central infusion of leptin on the hypothalamic
expression of mir-383 and mir-384-3p can be explained by the
peripheral effect of leptin. For instance, it has been shown that
leptin increases insulin secretion which in turn modulates the
POMC neurons activity and may modulate miRNA expression
(Ceddia et al., 1999; Hill et al., 2010).
Interestingly, bioinformatics prediction analysis indicates that
the miRNAs targeting POMC can also target genes involved
in the leptin signaling pathways such as STAT3 as well as
the leptin receptor. For instance, mir-488 could modulate the
expression of STAT3. These observations suggest that, mir-383,
mir-384-3p, and mir-488 in the arcuate nucleus are involved in a
complex network controlling the sensitivity of POMC neurons to
peripheral signals. Additional in vitro experiments could clarify
this last point. Recently, numerous studies identified several
miRNAs as important for the hypothalamic regulation of energy
homeostasis. Herzer et al. identified mir-7a as a hypothalamic-
enriched miRNA with a high expression in Neuropeptide
Y/Agouti-related orexigenic peptide neurons (Herzer et al.,
2012). Interestingly, two extreme conditions of nutritional stress,
i.e., caloric restriction and high fat diet-induced obesity, modified
the hypothalamic pattern of expression of a set of miRNAs
including let7a,mir-9∗,mir-30e,mir-132,mir-145,mir-200a, and
mir-218 (Sangiao-Alvarellos et al., 2014). Taken altogether, these
different studies point to the importance of miRNAs as regulators
and sensors of central energy homeostasis.
In conclusion, we observed that the impairment of leptin
synthesis or signaling, induced a defect in the hypothalamic
expression of a subset of miRNAs that target POMC 3′UTR. It
was observed that mir-383, mir-384-3p, and mir-488 were up-
regulated in ob/ob and db/db mice and mir-488 was down-
regulated in leptin-treated mice. This indicates that the miRNAs
that target POMC important mediators of leptin action in the
hypothalamus. New miRNAs modulated by leptin could open
important therapeutic perspectives for controlling metabolic
disorders.
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